Nowadays, Chronic HCV is easily managed with medications unliked earlier. And it is possible to attained 99% of sustained viral response in its early phase with availability of newer drugs.
These are pangenotype drugs and can be advised to patients of HCV disease whatever may be the genotype is.
1. Velpatasavir (100mg): It is a NS5A inhibitor with more potency than the next one but with less overcoming effect to any resistance.
2. Sofosbuvir (400mg): This drug inhibits the NS5B (NS: Non-Structural protein of the Hepatitis C Virus).
Both are prescribed together with OD dosing for 12 weeks.
Popular brand name: Resof total.